Real-time, in vivo rodent imaging, allows researchers to observe and monitor several normal and abnormal biological processes. Data collected using the eyes series, provides crucial initial insights and generate quantitative results that, in combination with the Visual | eyesTM interface, compose an essential platform for every preclinical laboratory.
Oncology
Non-invasively assess your agent's targeting properties, real-time monitor drug delivery and track tumor progression.
Infection, Inflammation
Acquire detailed insights into disease mechanisms, enhance more accurate diagnostics while supporting the development or improvement of new or already existing therapeutics.
Protocol optimization
Test different animal preparation conditions, drug concentrations and administration routes to optimize your protocols.
Quick insights
Scan the same mouse at multiple time points to determine the optimal moments for 3D imaging. Conduct super-fast QC to exclude faulty injected subjects from further and more complex studies.
Applications with eyes™
Cardiac PET, Stroke
Cardiac PET imaging using ¹⁸F-FDG
Cardiac PET imaging in a mouse model of myocardial infarction. Image info: 80 min post injection - 20 min scan - total injected dose 6 MBq
Oncology, alpha-emitters, SPECT
Ac-225 imaging using γ-eye™
In vivo imaging of alpha-emitting isotopes made possible, with BIOEMTECH technology. Two illustrative images, from two timepoints: 2h and 24h post injection with a Ac-225 radiopharmaceutical, in an oncology model. Image info: Scan duration 10 min. Dose injected: 3.5 μCi / 0.13 MBq. Images acquired at Radiomedix laboratories.
PET
Using Zr-89 for lungs imaging
In vivo imaging of free Zr-89 accumulation in the lungs of a healthy mouse following intratracheal administration. Imaging parameters: 30 min post-administration static acquisition - injected activity 94.4 μCi - acquisition time 5min.